Results 211 to 220 of about 587,910 (342)

Respiratory tract infections

, 2015
Peter Davey, Mark Wilcox, William Irving, Guy Thwaites   +3 more
openaire   +2 more sources

Magnitude and outcomes of lower respiratory tract infections attributed to multi-drug resistant bacteria among critically ill patients at a tertiary center in Jordan.

Hamzah Mohd, Obada Mohammad, Omar Omar, Mohammad Wardat, Saad A. Mahmoud, Ghaith Batarseh, Malek Ennab, Dua Steitieh   +7 more
openalex   +2 more sources

Bedside clinical assessment predicts recurrence after hospitalization due to viral lower respiratory tract infection in young children

, 2019
Maria Arroyo, K. Salka, Geovanny F. Pérez, Carlos E. Rodríguez‐Martínez, José A. Castro‐Rodríguez, Gustavo Niño   +5 more
openalex   +2 more sources

Population Pharmacokinetics of Clesrovimab in Preterm and Full‐Term Infants

Clinical Pharmacology &Therapeutics, EarlyView.
Clesrovimab is a half‐life extended monoclonal antibody targeting the respiratory syncytial virus fusion protein. Three studies (phase Ib/IIa [MK‐1654‐002], phase IIb/III [CLEVER], and phase III [SMART]) were conducted to evaluate the efficacy, safety, and pharmacokinetics (PK) of clesrovimab in infants.
Ziheng Hu, Farina Hellmann, Xiaowei Zang, Nele Plock, Keyur Parmar, Radha A. Railkar, S. Y. Amy Cheung, Brian M. Maas, Ferdous Gheyas   +8 more
wiley   +1 more source

Risk factors of respiratory tract infection in patients after surgery under general anesthesia and nursing countermeasures. [PDF]

Afr Health Sci
Xu X, Zhao Y.
europepmc   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Epidemiological shift and clinical characteristics of rhinovirus genotypes in acute respiratory tract infection cases in Kunming, China, from 2019 to 2023. [PDF]

Front Cell Infect Microbiol
Zhang G, Ba L, Liu L, Su T, Zhu H, Xu Y, Zhang Y, Huang Y, Fan X, Wan J, Gao J, Li H, Su M.   +12 more
europepmc   +1 more source

Erratum: Human metapneumovirus in pediatric patients with acute respiratory tract infections in the Aseer region of Saudi Arabia

, 2019

openalex   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant, Matthias Schmitt, Anna B. Reid, Clifford J. Garratt, William G. Newman, Aneil Malhotra, Rhys Beynon, Masliza Mahmod, Betty Raman, Robert M. Cooper, Dana Dawson, Thomas Green, Sanjay K. Prasad, Anvesha Singh, Susanna Dodd, Hugh Watkins, Stefan Neubauer, Christopher A. Miller   +17 more
wiley   +1 more source

Multiplex PCR for lower respiratory tract infection diagnosis in ICU and non-ICU settings: enhancing diagnostic stewardship in Indian tertiary care. [PDF]

Iran J Microbiol
Singh R, Kakati B.
europepmc   +1 more source